Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites
about
Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanilMalarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, NigeriaComparative whole genome transcriptome analysis of three Plasmodium falciparum strains.4(1H)-pyridone and 4(1H)-quinolone derivatives as antimalarials with erythrocytic, exoerythrocytic, and transmission blocking activitiesDifferent mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance markerPlasmodium falciparum susceptibility to antimalarial drugs: global data issued from the Pasteur Institutes international networkStructural Plasticity of Malaria Dihydroorotate Dehydrogenase Allows Selective Binding of Diverse Chemical ScaffoldsMutations in the P-Type Cation-Transporter ATPase 4, PfATP4, Mediate Resistance to Both Aminopyrazole and Spiroindolone AntimalarialsImaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug DiscoveryIdentification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparumEffects of atovaquone and diospyrin-based drugs on the cellular ATP of Pneumocystis carinii f. sp. cariniiResistance of a rodent malaria parasite to a thymidylate synthase inhibitor induces an apoptotic parasite death and imposes a huge cost of fitnessMitotic evolution of Plasmodium falciparum shows a stable core genome but recombination in antigen familiesPrediction of the P. falciparum target space relevant to malaria drug discoveryReconstructing the Qo site of Plasmodium falciparum bc 1 complex in the yeast enzymeSequence Polymorphism of Cytochrome b Gene in Theileria annulata Tunisian Isolates and Its Association with Buparvaquone Treatment FailureDelayed Onset of Symptoms and Atovaquone-Proguanil Chemoprophylaxis Breakthrough by Plasmodium malariae in the Absence of Mutation at Codon 268 of pmcytbEvidence of a Mild Mutator Phenotype in Cambodian Plasmodium falciparum Malaria ParasitesTargeting purine and pyrimidine metabolism in human apicomplexan parasitesHigh-Throughput Luciferase-Based Assay for the Discovery of Therapeutics That Prevent MalariaMolecular surveillance as monitoring tool for drug-resistant Plasmodium falciparum in Suriname.Mutations in the Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL) Confer Multidrug ResistanceParasites resistant to the antimalarial atovaquone fail to transmit by mosquitoesParameters determining the relative efficacy of hydroxy-naphthoquinone inhibitors of the cytochrome bc1 complex.Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm.In vitro and in vivo activities of 1-hydroxy-2-alkyl-4(1H)quinolone derivatives against Toxoplasma gondii.Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assayAminoindoles, a novel scaffold with potent activity against Plasmodium falciparum.Plasmodium chabaudi chabaudi malaria parasites can develop stable resistance to atovaquone with a mutation in the cytochrome b genePlasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy.Toxoplasma gondii: 25 years and 25 major advances for the fieldUbiquinone synthesis in mitochondrial and microsomal subcellular fractions of Pneumocystis spp.: differential sensitivities to atovaquone.Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reportsAntiparasitic agent atovaquoneMalaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens.Human disease-related mutations in cytochrome b studied in yeast.Prevention of infection caused by Pneumocystis carinii in transplant recipients.The phenothiazinium chromophore and the evolution of antimalarial drugs.Uncovering the molecular mode of action of the antimalarial drug atovaquone using a bacterial system.Molecular basis for atovaquone binding to the cytochrome bc1 complex.
P2860
Q21034152-E2A3B37E-C857-4BE7-873A-512B8478016DQ21245928-1536C739-6237-47FF-B979-468DB463CD50Q24540624-DB17C121-2E78-47C1-8F5E-8C3F91662C12Q24757085-41201657-DACE-4362-B8C1-7A2948814E44Q24806780-EF93F2CB-E7B9-4A37-A9FA-B01FB4869753Q26860875-A9F2B8EF-311A-4A09-8AD0-7833F6B4EF54Q27656755-C1F8F9FF-1440-4998-936A-1D3749D30CAEQ27861952-9755AA7C-C641-4610-8F3E-E11BD172E77AQ27861956-4FE9E3C9-1A0A-4F31-9EFC-D42286134FADQ27972613-D09CCBC4-0B10-41A7-B096-DC53CFB568EDQ28343926-CB263E2B-7FB1-453F-82D0-6D64EBC7D9C6Q28478613-0BD240CC-9881-4510-AAC9-8CCB13B8892CQ28486079-5F0EAE89-A4A2-4D1F-9C29-5A62B80CB685Q28534474-F53AB5C9-CBAB-4F92-8288-C163FC844BDCQ28535248-4629819F-342E-41C8-96FA-1AEFDFF0C8A3Q28548056-72876562-52A3-48A4-BD72-B96C758B753FQ28550420-D5860697-16CF-425B-B918-D7BFD9788F60Q28551519-9D027B40-83A1-4D9F-B527-0EED7BD500FFQ28629739-591111B2-540E-4C58-9F95-09367CFCE6BFQ28829342-2B00F906-402C-4CF8-BF79-65F610F21819Q29353745-A8ACDED3-D5D7-4EC9-89AB-E8C6E85B6927Q30047024-50C73DB8-CFF6-4D81-8A2F-E68BDB3B638EQ30380109-0EED31E1-3709-4AD1-9478-3E95946123CDQ33279892-75EDDC3F-A165-43C5-A7C5-9946EFDE1CDBQ33440113-69C3EB3E-434E-4ED5-A7C6-BC04CA2DF608Q33558897-E2328F1B-C972-449B-A90A-705ED8341AAAQ33604021-65EAC0C3-AFAD-449C-A5E0-B177D93DD52AQ33851108-2196217F-E860-4BD7-A7EC-71A691BB7333Q33898569-E26FB91F-B810-4CEF-991E-45EEBDD67D68Q33903812-4E23D3A3-259B-4B65-B72C-BE4F404B4F9EQ33956789-6A50B151-1F23-4B24-A563-5514EC6A39CEQ33995575-1AA37C7E-7230-4BC3-A15F-46F0B255A8EAQ34058304-E0C2B432-9575-4FC0-9246-8EA3361869BDQ34107885-35CDEFF4-5A7B-4BDE-8088-0B29254A28A0Q34289235-5CECE1B7-4686-4286-A68E-0A44E2156E67Q34289315-00CE3DAB-F543-4DC5-9360-0E407F71F0B3Q34374874-F182898A-23D9-44D4-83D0-028FABEF14BDQ34424514-A0F19D2D-852E-41FE-910F-E21E433C7119Q34499482-943436AA-3606-4DDC-AE50-7EFF15780045Q34534276-F71D0F3D-0826-4A69-B1F2-AE523965D832
P2860
Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Resistance mutations reveal th ...... ochrome b in malaria parasites
@ast
Resistance mutations reveal th ...... ochrome b in malaria parasites
@en
Resistance mutations reveal th ...... ochrome b in malaria parasites
@nl
type
label
Resistance mutations reveal th ...... ochrome b in malaria parasites
@ast
Resistance mutations reveal th ...... ochrome b in malaria parasites
@en
Resistance mutations reveal th ...... ochrome b in malaria parasites
@nl
prefLabel
Resistance mutations reveal th ...... ochrome b in malaria parasites
@ast
Resistance mutations reveal th ...... ochrome b in malaria parasites
@en
Resistance mutations reveal th ...... ochrome b in malaria parasites
@nl
P2093
P2860
P3181
P1476
Resistance mutations reveal th ...... ochrome b in malaria parasites
@en
P2093
A B Vaidya
E Darrouzet
I K Srivastava
J M Morrisey
P2860
P304
P3181
P356
10.1046/J.1365-2958.1999.01515.X
P407
P577
1999-08-01T00:00:00Z